Top Biotech Companies in Hyderabad (33)
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The predictive power of Schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries.
Schrödinger, Inc.'s Top Stability & Growth Strengths
Strong Revenue Growth: Total revenue increased to $255.9M in 2025 with software up and drug‑discovery more than doubling, while operating expenses declined year over year. Early 2026 also showed momentum, with first‑half revenue modestly higher and Q2 posting year‑over‑year growth.
Strategic Partnerships: New and expanded agreements—such as Bristol Myers Squibb deploying Bunsen and a July 2026 discovery collaboration with Simcere—broaden platform use and collaboration optionality. The Lilly/Ajax transaction also validated the model and supported a higher 2026 drug‑discovery outlook.
Product Line Growth: The introduction of Bunsen, an agentic AI co‑scientist, expands the software portfolio and is being deployed at scale within BMS. This product push complements growth in ACV and broader platform adoption.
Established in 2012, Tierra Seed Science Private Limited is a next generation agriculture technology company focused on developing innovative seeds stacked with proprietary traits (Non Genetically Modified) that apart from providing significant yield and cost advantage to farmers, has very high impact on environment. Founded by professionals with more than seven decades of combined seed and agribusiness industry experience. Tierra...
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together...
Syneos Health's Top Stability & Growth Strengths
Strong Market Position & Advantage: Company materials and third‑party recognition portray a fully integrated CRO/CCO with leadership status, including widespread involvement in recent FDA/EMA novel therapies and recognition as a leading pharmacovigilance provider.
Strategic Partnerships: Recent collaborations with Microsoft and KX are positioned to enable AI‑driven efficiencies across clinical and commercial operations, with reported improvements in cycle times supporting operational scalability.
Investor Backing & Capital Strength: The 2025 take‑private by investment groups (including Elliott and Veritas) provides financial sponsorship to pursue tech‑enabled growth and operational repositioning.
Agriculture and DCM Shriram Limited are often spoken of in the same breath. When DCM Shriram Limited took over the management of Bioseed in 2002, the move was seen as yet another initiative by DCM Shriram Limited to create value in the farmlands of India and beyond. Huge investments in people, research labs and seed processing infrastructure followed the takeover. Today, Bioseed...
CLONZ is a biopharmaceutical firm promoted by a group of young and passionate Biotechnologists, focused on the development, manufacturing and commercialization of Human Therapeutic biosimilar Monoclonal Antibodies (MAbs). Clonz got incorporated in 2009 and started its operations in September 2010 at Genome Valley, Hyderabad, India With experienced team coming from recognized leaders in recombinant biosimilar manufacturing, Clonz is committed to delivering...
Welcome to LifeCell, where innovation thrives and caring for your health is at the heart of everything we do. We believe in the power of science and technology to transform lives, and we're on a mission to make advanced healthcare accessible and affordable to all. At LifeCell, we understand that your health is not just a number on a chart, but...
PopVax is an Indian biotechnology company based in Hyderabad building a novel thermostable, low-cost, and safe second-generation mRNA platform for rationally-designed broadly-protective multi-epitope vaccines. We’re starting with an open-source 4-8 °C refrigerator-stable booster candidate that is intended to protect against the entire sarbecovirus sub-family, including current and future strains of SARS-CoV-2 (the virus which causes COVID-19), and some other beta-coronaviruses...
Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier and more sustainable. From the food you eat to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe,...
Established in 1991, Krebs undertakes both contract manufacturing for large pharmaceutical and multinational companies and develops products for sale in global markets. Krebs is listed on NSE and BSE in India and is headquartered in Hyderabad, India.
Piramal Group is an Indian multinational conglomerate with a presence across healthcare, life sciences, drug discovery, financial services, alternative investment, and real estate.
Sanzyme is the first generation biotech healthcare company, established in 1969 as the first Indo-Japanese JV with Sankyo, Japan. Then it was called as Uni-Sankyo. Sanzyme is a specialist in Healthcare specialities covering Infertility gonadotropins, probiology, sexology, nephrology, urology and nutraceuticals. Sanzyme's fermentation wing is into aqua, poultry, veterinary probiotics in addition to recent bioremediation initiative. Sanzyme has three manufacturing...
JK Agri Genetics Limited is one of the few recognized agri-input companies in India. It is mainly into the business of production, processing and marketing of high quality hybrid seeds for different crops like Bajra, Jowar, Paddy, Cotton, Maize, vegetables, etc. and micronutrients and growth promotors. The Company has acquired over 30 years of experience in this business and is...
Cryoviva Biotech Private Limited was founded in 2006 by RJ Corp. The company is focused on providing high-quality umbilical cord blood stem cell processing, and storage for both private and public donation purposes. Based at Gurgaon with networks in all the towns of India provides a high end processing and storage technology which are approved by International authorities.
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Novartis's Top Stability & Growth Strengths
Strong Revenue Growth: Novartis shows multi-year sales expansion, with full-year results indicating continued top-line growth driven by priority brands across several therapeutic areas.
Profitability: Margins and operating income are described as strengthening, with core operating margin reaching about 40% alongside year-over-year core operating income growth.
Innovation-Driven Growth: Growth is supported by scaling priority brands and a deep pipeline with multiple high-value assets, alongside business development to add late- and mid-stage programs.
SDC delivers top-tier clinical trial services to pharmaceutical, biologic, and medical device/diagnostic companies since 2005. We are committed to providing experienced teams who will take ownership of your needs and are positively engaged in your projects. With strategic scientific consulting and clinical data services (biostatistics, data management/EDC, and IRT/IWRS) expertise at our core, our services are scalable via our diverse...
Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow. Our Vision is to support our global innovator partners bring 25 new medicines to life by 2025. And we are well on that journey.
Clearsynth Labs Limited is a technology oriented and research driven enterprise with the World’s Largest Inventory of High-end research products. Specializes in Stable Isotope Labeled compounds, the synthesis of reference standards, Metabolites, Impurities, Glucuronides, Chiral Compounds and also undertake custom synthesis of complex Molecules or “Difficult to Synthesize” compounds/Intermediates. We have around 200 employees worldwide with it’s Headquarter and Research &...
At Enveda, we are systematically translating molecules found in medicinal plants into new drugs for challenging diseases. Our platform harnesses nature's complexity with the help of cutting-edge advancements in knowledge graphs, machine learning, and metabolomics.
Endpoint is an interactive response technology (IRT®) systems and solutions provider that supports the life sciences industry. Since 2009, we have been working with a single vision in mind, to help sponsors and pharmaceutical companies achieve clinical trial success. Our solutions, realized through the proprietary PULSE® platform, have proven to maximize the supply chain, minimize operational costs, and ensure timely...
Endpoint Clinical, Inc.'s Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is repeatedly characterized as a global leader in RTSM/IRT with substantial operating scale, supporting 2,000+ studies across 90+ countries and 800+ active studies. This breadth and ability to handle complex, global trials provide a durable competitive edge.
Investor Backing & Capital Strength: The June 2024 acquisition by Arsenal Capital Partners supplies focused capital and sponsor support to accelerate expansion and innovation. This backing is presented as validation of market position and a catalyst for the next phase of growth.
Innovation-Driven Growth: Five generations of purpose-built RTSM platforms and the proprietary PULSE platform, including faster study builds in four weeks or less, indicate sustained product advancement. A 2025 brand refresh and continued tech investment underscore a roadmap aimed at pushing RTSM forward.

























.jpg)







